These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32611581)

  • 1. Cognitive Impairment in Patients with Breast Cancer before Surgery: Results from a CANTO Cohort Subgroup.
    Lange M; Hardy-Léger I; Licaj I; Pistilli B; Rigal O; Le Fel J; Lévy C; Capel A; Coutant C; Meyer J; Lerebours F; Petrucci J; Vanlemmens L; Brion M; Campone M; Soulié P; Blain M; Vaz-Luis I; Giffard B; Martin AL; Everhard S; André F; Dauchy S; Joly F
    Cancer Epidemiol Biomarkers Prev; 2020 Sep; 29(9):1759-1766. PubMed ID: 32611581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of groups of patients with cognitive complaints at breast cancer diagnosis: Results from a sub-study of the French CANTO cohort.
    Hardy-Leger I; Charles C; Lange M; Joly F; Roux P; Capel A; Petrucci J; Rigal O; Le Fel J; Vanlemmens L; Everhard S; Martin AL; Vaz Luis I; Coutant C; Cottu P; Levy C; Lerebours F; Andre F; Licaj I; Dauchy S
    Psychooncology; 2021 Apr; 30(4):463-470. PubMed ID: 33052613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive change in breast cancer patients up to 2 years after diagnosis.
    Lange M; Lefevre Arbogast S; Hardy-Léger I; Rigal O; Le Fel J; Pistilli B; Petrucci J; Lévy C; Capel A; Coutant C; Médeau L; Lerebours F; Vanlemmens L; Brion M; Bourbouloux E; Blain M; Binarelli G; Vaz-Luis I; Giffard B; Querel O; Everhard S; André F; Charles C; Dauchy S; Joly F
    J Natl Cancer Inst; 2023 Mar; 115(3):322-331. PubMed ID: 36571503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
    Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
    Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of cognitive impairment and breast cancer survivorship on quality of life in younger breast cancer survivors.
    Von Ah D; Crouch AD; Monahan PO; Stump TE; Unverzagt FW; Storey S; Cohee AA; Cella D; Champion VL
    J Cancer Surviv; 2022 Aug; 16(4):812-822. PubMed ID: 34173970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Objective-subjective disparity in cancer-related cognitive impairment: does the use of change measures help reconcile the difference?
    O'Farrell E; Smith A; Collins B
    Psychooncology; 2017 Oct; 26(10):1667-1674. PubMed ID: 27278814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in the first year after breast cancer diagnosis: A prospective cohort study.
    Ramalho M; Fontes F; Ruano L; Pereira S; Lunet N
    Breast; 2017 Apr; 32():173-178. PubMed ID: 28208082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognition, quality-of-life, and symptom clusters in breast cancer: Using Bayesian networks to elucidate complex relationships.
    Xu S; Thompson W; Ancoli-Israel S; Liu L; Palmer B; Natarajan L
    Psychooncology; 2018 Mar; 27(3):802-809. PubMed ID: 29055062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-reported cognitive functioning in postmenopausal breast cancer patients before and during endocrine treatment: findings from the neuropsychological TEAM side-study.
    Schilder CM; Seynaeve C; Linn SC; Boogerd W; Beex LV; Gundy CM; Nortier JW; van de Velde CJ; van Dam FS; Schagen SB
    Psychooncology; 2012 May; 21(5):479-87. PubMed ID: 21351188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive impairment in older patients with breast cancer before systemic therapy: is there an interaction between cancer and comorbidity?
    Mandelblatt JS; Stern RA; Luta G; McGuckin M; Clapp JD; Hurria A; Jacobsen PB; Faul LA; Isaacs C; Denduluri N; Gavett B; Traina TA; Johnson P; Silliman RA; Turner RS; Howard D; Van Meter JW; Saykin A; Ahles T
    J Clin Oncol; 2014 Jun; 32(18):1909-18. PubMed ID: 24841981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of baseline cancer-related cognitive impairment in cancer patients scheduled for a curative treatment.
    Lycke M; Pottel L; Pottel H; Ketelaars L; Stellamans K; Van Eygen K; Vergauwe P; Werbrouck P; Goethals L; Schofield P; Boterberg T; Debruyne PR
    Psychooncology; 2017 May; 26(5):632-639. PubMed ID: 27338029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of physical exercise on cognitive function after chemotherapy in patients with breast cancer: a randomized controlled trial (PAM study).
    Koevoets EW; Schagen SB; de Ruiter MB; Geerlings MI; Witlox L; van der Wall E; Stuiver MM; Sonke GS; Velthuis MJ; Jobsen JJ; Menke-Pluijmers MBE; Göker E; van der Pol CC; Bos MEMM; Tick LW; van Holsteijn NA; van der Palen J; May AM; Monninkhof EM;
    Breast Cancer Res; 2022 May; 24(1):36. PubMed ID: 35619188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.
    Vardy JL; Dhillon HM; Pond GR; Rourke SB; Bekele T; Renton C; Dodd A; Zhang H; Beale P; Clarke S; Tannock IF
    J Clin Oncol; 2015 Dec; 33(34):4085-92. PubMed ID: 26527785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a new online cognitive assessment tool in breast cancer survivors with cognitive impairment: a prospective cohort study.
    Bellens A; Roelant E; Sabbe B; Peeters M; van Dam PA
    Support Care Cancer; 2022 Jan; 30(1):21-31. PubMed ID: 34347183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived and objective cognitive impairment in newly diagnosed versus established multiple sclerosis: impact of disease duration.
    McNicholas N; Tubridy N; Hutchinson M; McGuigan C
    Ir J Med Sci; 2021 Aug; 190(3):1149-1154. PubMed ID: 33108620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
    Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM; Eberling J; Espay AJ; Foster ED; Leverenz JB; Litvan I; Richard I; Troyer MD; Hawkins KA;
    Mov Disord; 2015 Jun; 30(7):919-27. PubMed ID: 25737166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous Response of Chemotherapy-Related Cognitive Decline in Patients with Breast Cancer: A Prospective Study.
    Schrauwen W; Van de Cavey J; Vingerhoets G; Vanheule S; Van den Broecke R; Denys H
    J Int Neuropsychol Soc; 2020 Sep; 26(8):806-814. PubMed ID: 32312360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
    Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
    Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with cognitive impairment during the first year of treatment for nonmetastatic breast cancer.
    Rodriguez N; Fawcett JM; Rash JA; Lester R; Powell E; MacMillan CD; Garland SN
    Cancer Med; 2021 Feb; 10(4):1191-1200. PubMed ID: 33455070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.